🟢 Kailera Therapeutics is trading 5% up today in after-hours trading after consecutive declines

Kailera Therapeutics is trading at $17.20 (+4.81%) after rebounding from consecutive declines, including a 5.00% drop on August 31.

• Shares gained 6.56% during the September 1, 2026 regular session.
• No verified September 1 company-specific announcement or earnings catalyst was identified.
• The latest major release was August 12 quarterly results and business updates; broader markets declined, so global sentiment does not clearly explain the gain.